Navigation Links
Modeling Simulation Predicts Potential Negative Impact on U.S. Blood Supply if ESA Use Limited for Chemotherapy-Induced Anemia
Date:12/10/2007

ATLANTA, Dec. 10 /PRNewswire/ -- A new analysis presented today at the American Society of Hematology (ASH) 49th Annual Meeting and Exposition predicts that limiting the use of erythropoiesis-stimulating agents (ESAs) for chemotherapy-induced anemia (CIA) would place considerable pressure on the available marginal U.S. blood supply. Using a modeling simulation technique that allowed for varying the magnitude of reduction in ESA use, findings suggested that even at the lowest reduction evaluated, 25 percent, there was a substantial impact on the available marginal blood supply.

"The nation's blood supply is a limited resource and this analysis underscores the vulnerability of the situation," said Francis Vekeman, M.A., Economist, Groupe d'analyse, Ltee, and lead author of the new analysis. "Given the small margin between usable blood and transfusion demand, understanding the impact of limiting ESA use in cancer chemotherapy patients is essential. Over the last 18 years, a large body of scientific data has demonstrated the ability of ESAs to help patients avoid blood transfusions."

Background

Between 1987 and 1997, the demand for allogeneic blood [whole blood and packed red blood count (RBC)] in the U.S. decreased due to safety concerns. In the same period, the blood supply also decreased, resulting in a 48 percent reduction in the margin between available supply and demand. Despite increases in both supply and demand by 2004, the last year data was available, the margin further declined to only 6.1 percent (allogeneic blood collection of 14.8 million units and transfusion at 13.9 million units). After screening, 240,000 units were rejected leaving a margin of only 648,000 units available, or 4.5 percent of the supply.

Study Methodology

The primary purpose of the study was to estimate the impact of limiting the use of ESAs for CIA patients on the U.S. blood supply.

A modeling simulation was used to compare the number of
'/>"/>

SOURCE Ortho Biotech Products, L.P.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Chromatin remodeling complex connected to DNA damage control
2. A classic method for modeling skin cancer is featured in Cold Spring Harbor Protocols
3. Sixteen Organizations Implement ACG Rx-PM Predictive Modeling from Johns Hopkins University, DST Health Solutions
4. Mayo Clinic Multidisciplinary Simulation Center Receives Distinction as an ACS-Accredited Education Institute
5. B-Line Medical(TM) and the Center for Medical Simulation Announce Partnership
6. Running shipwreck simulations backwards helps identify dangerous waves
7. Medical Simulation Corporation Announces Partnership with Methodist DeBakey Heart Center in Houston
8. Medical Simulation Corporation Launches Sales Force Training Program
9. ANSYS and Network Analysis Team Up to Improve Thermal Simulation
10. Medical Simulation Corporation Announces Partnership With University of Pennsylvania Health System
11. First biomarker discovered that predicts prostate cancer outcome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... Trail, NC (PRWEB) May 05, 2015 ... serving Indian Trail, Monroe, Matthews, Charlotte and surrounding areas. ... the field of accounting. This company provides assistance in ... priority as they prepare individual or corporate tax returns ... system in the cloud that allows clients (and Carlini ...
(Date:5/5/2015)... NY (PRWEB) May 05, 2015 Leveraging ... Clinic in Greece, an experienced team of fertility ... of infertility for patients around the globe. , “We’re ... VisitandCare.com. Greece unquestionably remains a global leader in reproductive ... and hard-working fertility specialists in the world who play ...
(Date:5/5/2015)... From the halls of Microsoft Ignite ... enabling enterprise collaboration across platforms and devices, today ... and simplify the move to Microsoft Office 365. ... Office 365 enable organizations to migrate to ... adoption and effectively managing critical business data on ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 Dr. Patricia ... pulmonary hypertension (PH). A pulmonologist and pulmonary hypertension specialist ... was attending a work event when an initial idea ... “I was sitting in the audience at the 2010 ... team of healthcare providers – were recalling their climb ...
(Date:5/5/2015)... year, PolyU researchers garnered two Grand Prizes, two Special ... and four Silver Medals at the world-renowned event. The ... Prize and Gold Medal with the Congratulations of Jury:, ... Investigator: Dr Allan Chee-kooi CHAN, Institute of Textiles and ... the “mannequin” for many tasks involved in apparel design, ...
Breaking Medicine News(10 mins):Health News:Maternity Health IVF Clinic in Greece Demonstrates Industry-Leading Fertility Technology 2Health News:Maternity Health IVF Clinic in Greece Demonstrates Industry-Leading Fertility Technology 3Health News:AvePoint Unveils New Solutions for Microsoft Office 365 & Azure at Microsoft Ignite 2015 2Health News:AvePoint Unveils New Solutions for Microsoft Office 365 & Azure at Microsoft Ignite 2015 3Health News:World PH Day: Team PHenomenal Hope Races to Spread the Word about Pulmonary Hypertension 2Health News:PolyU wins top prizes in Geneva’s Invention Expo 2Health News:PolyU wins top prizes in Geneva’s Invention Expo 3Health News:PolyU wins top prizes in Geneva’s Invention Expo 4Health News:PolyU wins top prizes in Geneva’s Invention Expo 5
... ... Benjamin was recently named to the advisory board for PerfectServe, a healthcare communications ... serving physician practices and hospitals nationwide. , ... Knoxville, Tenn. (PRWEB) September 15, 2009 -- ...
... , Peripheral Arterial Disease Coalition Joins ... Individuals and Healthcare System , , ... of the nation,s leading voices in the health disparities discussion, is ... code peripheral arterial disease (P.A.D.) prevalence down to the street ...
... BC, Sept. 15 /PRNewswire-FirstCall/ - avVaa World Health Care ... manufacturer and distributor of nationally branded therapeutic, natural skin ... first DRTV test week. , avVaa World Health Care ... Neuroskin(R) Psoriasis Relief DRTV media campaign. A total of ...
... , , , ... Susan Olmetti , one must only step forward into the ... of unconventional characters housed in an outlying charismatic Chicago suburb - a ... by more than 75 locally owned, independent businesses and a significant gay ...
... , , , EAST LANSING, ... of the American auto industry could affect United Auto Workers (UAW) ... Michigan State Medical Society and the Michigan Dental Association on Thursday, ... Showplace in Novi. , , Conference speakers will ...
... , LOS ANGELES, Sept. 15 In a market ... in for a challenge when he founded RED Light (R) ... business plan in place and the marketing vision to position RED Light ... elixir. , , (Photo: http://www.newscom.com/cgi-bin/prnh/20090915/AQ75816 ) , , ...
Cached Medicine News:Health News:Judy Benjamin Named to PerfectServe Advisory Board 2Health News:National Minority Quality Forum Creates Advanced, Precision Tracking Tool to Address Prevalence of Peripheral Arterial Disease 2Health News:National Minority Quality Forum Creates Advanced, Precision Tracking Tool to Address Prevalence of Peripheral Arterial Disease 3Health News:avVaa World Health Care Products, Inc. Announces DRTV Test Results 2Health News:avVaa World Health Care Products, Inc. Announces DRTV Test Results 3Health News:Wine Reception Mixing up one Part Abstract Artist Susan Olmetti, one Part Chicago House Fundraiser, and one Part SIR Spa 2Health News:'Future of Autos, Future of Health Care' to Be Examined by the Michigan State Medical Society and the Michigan Dental Association 2Health News:RED Light Energy Elixir is Enticing Consumers With its 'Original Seduction,' Positioning the Brand for Mounting Success 2
(Date:5/5/2015)... SAN FRANCISCO , May 5, 2015 ... a Small Business Innovation Research (SBIR) grant from the ... Creek is a San Francisco ... therapeutics to selectively repair tissues damaged by disease. This ... therapeutics engineered to repair heart tissue following a heart ...
(Date:5/5/2015)... , May 5, 2015 Ardelyx, Inc. ... focused on cardio-renal, gastrointestinal, and metabolic diseases, today ... evaluating tenapanor in Stage 3 chronic kidney disease ... did not meet the primary endpoint of decreasing ... to patients receiving placebo. Ardelyx ...
(Date:5/5/2015)... , May 5, 2015 North ... $94.9 million in 2014, and is estimated to grow ... 7.8% from 2014 to 2019. Browse through ... Market for an analysis of industry trends and segments, ... http://www.micromarketmonitor.com/market/north-america-glaucoma-surgery-devices-8830146604.html Early buyers ...
Breaking Medicine Technology:Silver Creek Pharmaceuticals Awarded NIH SBIR Grant for Smart Growth Factor Technology 2Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 2Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 3Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 4Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 5Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 6North America Ophthalmology Glaucoma Surgery Device Market is Expected to Reach $138.3 Million by 2019, at a CAGR of 7.8% From 2014 to 2019 2North America Ophthalmology Glaucoma Surgery Device Market is Expected to Reach $138.3 Million by 2019, at a CAGR of 7.8% From 2014 to 2019 3
... Further,Scientific Validation of the Potential Utility of Modigene,s CTP Technology ... ... -, VIENNA, Va., Sept. 24 Modigene Inc. (OTC,Bulletin Board: ... edition of the journal Endocrinology showing that,erythropoietin (EPO) linked to Modigene,s ...
... FRAMINGHAM, Mass., Sept. 24 Iodine has been ... has been written about molecular,iodine yet many women ... studies being conducted may soon yield an effective,nonhormonal ... drugs on the market, all,available hormonal therapies have ...
Cached Medicine Technology:Study Published in Endocrinology Reports Potential of Modigene Technology to Extend Duration of Protein Drugs 2Study Published in Endocrinology Reports Potential of Modigene Technology to Extend Duration of Protein Drugs 3Study Published in Endocrinology Reports Potential of Modigene Technology to Extend Duration of Protein Drugs 4Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease 2
... guidewire-mounted pressure sensor and continues to ... the only sensor on the market ... With significantly improved maneuverability and pushability, ... guidewire, as well as a valuable ...
... Now you can perform stereotactic, ultrasound and ... convenience of your office. Use the patented, ... easier and more clinically advanced method of ... best for the women who trust YOU.,12 ...
... you can perform stereotactic, ultrasound and MRI-guided ... of your office. Use the patented, FDA-cleared ... and more clinically advanced method of breast ... for the women who trust YOU.,9 Gauge ...
... can perform stereotactic, ultrasound and MRI-guided vacuum ... your office. Use the patented, FDA-cleared ATEC ... more clinically advanced method of breast biopsy. ... the women who trust YOU.,9 Gauge Handpieces: ...
Medicine Products: